Chemerin, another ligand of ChemR23, has been reported to improve infarct size, and neurological impairment by alleviating neuroinflammation and neuronal injury via ChemR23 after stroke or neonatal hypoxic-ischemic encephalopathy [17, 28]. The gene discussed is RARRES2; the disease is Stroke.